Development of a Direct Alhydrogel Formulation Immunoassay (DAFIA)

Daming Zhu1, Shuhui Huang, Elizabeth Gebregeorgis

  • 1Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD 20852, USA. dzhu@niaid.nih.gov

Summary

A new Direct Alum Formulation Immunoassay (DAFIA) accurately measures antigen content, identity, and integrity directly on Alhydrogel, improving vaccine quality control. This method avoids lengthy extraction steps and enhances sensitivity for low-dose antigen formulations.